News Agency
The Times

HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer

  • Written by PR Newswire
HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer

ROCKVILLE, Md. and SEOUL, South Korea, July 15, 2024 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today the appointment of Christopher W. Slavinsky as Chief Business Development and Legal Officer.

HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal OfficerHanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer

"Chris brings a wealth of expertise...

Read more: HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer

How Can Businesses Reduce the Risk of Commercial Litigation?

Commercial disputes often begin with a misunderstanding, an unclear contract or a delayed response to a growing problem. Seeking early advice from Litigation Lawyers Sydney with PCL lawyers can help businesses trust and identify legal risks, clarify obligations and create a strategy... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion